[Carcinoembryonic antigen, its clinical and prognostic significance in malignant tumors of the gastrointestinal system].
A radioimmunoassay to determine the CEA level in 100 patients with GIT malignant tumors was performed. The test was shown to be of particular value for making a preoperative prognosis of the disease. In operated on patients it could be used for early diagnosis of recurrences and metastases. The dynamic performance of the test made it possible to evaluate therapeutic efficacy.